Russian rouble slumps again as volatile year-end trade continues
9:12 am Wednesday, December 28th, 2022
By Alexander Marrow
MOSCOW (Reuters) -The rouble weakened sharply on Wednesday, sliding to the 72 mark against the dollar, as sanctions on Russian oil and their probable impact on export revenues put pressure on the Russian currency.
The rouble lost about 8% against the dollar last week and is on course for a hefty monthly decline after an oil embargo and price cap came into force. The finance ministry has said the recent slump is related to recovering imports.
By 1256 GMT, the rouble was 2.2% weaker against the dollar at 71.93 , earlier hitting 72.09 and moving in the direction of the almost eight-month low of 72.6325 struck last week.
It lost 1.8% to trade at 76.36 versus the euro and shed 2.3% against the yuan to 10.21.
The rouble has experienced high volatility in the past two weeks and is liable to sharp swings amid smaller trading volumes in the run up to Russia’s New Year holidays.
“The newly imposed Western sanctions have contributed to the recent falls in energy prices, which is certainly putting pressure on the rouble,” said Olga Yangol, head of emerging markets research and strategy for Americas at Credit Agricole CIB.
The rouble will be relatively resilient going forward though, Yangol added, expecting the oil price to be mainly driven by geopolitics and for OPEC+ to continue to trim its production in response to market fundamentals.
Brent crude oil, a global benchmark for Russia’s main export, was down 0.4% at $84.0 a barrel.
President Vladimir Putin on Tuesday delivered Russia’s long-awaited response to the Western price cap, signing a decree that bans the supply of crude oil and oil products from Feb. 1 for five months to nations that abide by the cap.
Russian stock indexes were lower.
The dollar-denominated RTS index was down 2.3% to 937.6 points. The rouble-based MOEX Russian index was 0.5% lower at 2,141.3 points.
For Russian equities guide see
For Russian treasury bonds see
(Reporting by Alexander Marrow; Additional reporting by Bansari Mayur Kamdar; Editing by Muralikumar Anantharaman and Chizu Nomiyama)
